← All Indian IPOs

INJECTO POLYMERS LIMITED IPO

Closed
BSE SME Book Building

11–16 Sep 2026

Price band ₹98–₹100
GMP
Subscribed 1.29×
Min to apply (retail) ₹2,40,000 1200 shares, one lot at the cap
↓ Download IPO analysis PDF

Latest update:

Subscribed 1.29× (QIB 1.6× · NII 1.2× · Retail 1.3×) · Price band ₹98–₹100 · Closed 16 Sep 2026 · Allotment 17 Sep 2026 (Confirmed) · Lists 21 Sep 2026 (Expected)

Subscriptionvia aggregator
QIB 1.57×
NII (total) 1.21×
Retail 1.28×
Offer document (RHP) ↗not cross-checked

What INJECTO POLYMERS LIMITED does

Injecto Polymers Limited is engaged in the manufacturing of a diverse range of plastic packaging products, including Polypropylene Woven Fabrics, Polypropylene Woven Bags, Biaxially Oriented Polypropylene (BoPP) bags, leno bags, Low Density and Polyester Pouches, Flexible Intermediate Bulk Containers (FIBC), and non-woven bags. The company also trades plastic granules and Polyvinyl Chloride (PVC) resins.

EBITDA margin
10.1%
Debt / Equity
2.61x
[!] High leverage: Debt-to-equity is 2.61, above the 2× mark. Debt is more than twice net worth.
[~] Profit not converting to cash: Operating cash flow is -305% of profit after tax. Less than half of reported profit arrived as cash — usually receivables or inventory build.
[+] Strong revenue growth: Revenue compounded 86% a year over 2 years. Revenue compounding above 20% a year.
[~] Margins compressing: EBITDA margin declined across the reported years.

INJECTO POLYMERS LIMITED financials

Rs crore  ·  Annual

Latest year highlighted in green. Sparklines show the trend.

202420252026
Sales 109261376
Operating Profit 122338
OPM % 11.3%8.6%10.1%
Net Profit 4816
Total Debt 83101165

INJECTO POLYMERS LIMITED IPO offer structure

Fresh issue: ₹56 cr

The offer-for-sale component is not stated in what we extracted from the offer document, so the full issue size and the split between the two are unknown. This figure is the fresh issue alone, not the total raise. Fresh issue proceeds go to the company; OFS proceeds go to selling shareholders.

Issue size and split come from a public aggregator rather than the exchange, cross-checked against a second one. The offer document states the offer-for-sale as a share count against a blank amount, so it cannot be read from the document itself.

Use of proceeds

INJECTO POLYMERS LIMITED promoters and holding

Before IPO 74.0%
After IPO 54.0%

INJECTO POLYMERS LIMITED strengths and risks

Company-stated strengths and disclosed risk factors from the offer document.

Strengths
  • Strong Customer Relationship (p.164)
  • Multi - Product Portfolio & Customisation Capabilities (p.164)
  • Locational Advantage of our manufacturing units (p.164)
  • Quality Standard Certifications & Quality Tests (p.164)
  • Experienced Promoter and Senior Management Team (p.164)
Risks
  • We derive a significant portion of our revenue from operations from a limited number of customers. (p.27)
  • We derive a significant portion of our revenue from operations from trading activities, exposing us to price volatility. (p.28)
  • A significant portion of our revenue from operations is generated from Eastern India, especially West Bengal. (p.30)
  • Inadequate or interrupted supply and price fluctuation of our raw materials could adversely affect our business. (p.30)
  • Our reliance for raw materials is highly dependent on a few limited numbers of suppliers. (p.30)

INJECTO POLYMERS LIMITED peer comparison: DRHP median P/E 14.2x

Live BSE prices
Company CMP P/E OPM% ROE% Source
Emmbi Industries Limited Rs 90 +1.2% 19.9x 9.0% 4.5% live
RDB Rasayans Limited Rs 163.4 -1.7% 9.0x 49.6% 18.5% live

P/E from offer document where live data unavailable. Not a fair-value judgement.

INJECTO POLYMERS LIMITED market and competition

We compete with large, organised companies as well as smaller regionally based competitors. Among listed companies of similar size and product portfolio in India, we face competition from listed peers like Emmbi Industries Limited and RDB Rasayans Limited.

INJECTO POLYMERS LIMITED outlook, as the document states it

We intend to continue to invest in increasing our manufacturing capacities and our operational efficiencies, thereby increasing our customer satisfaction and improving our sales and profitability. We are actively working to expand our presence across other regions in India and have taken certain initiatives to increase our presence in other geographies.

INJECTO POLYMERS LIMITED IPO: common questions

When does the INJECTO POLYMERS LIMITED IPO open and close?

The INJECTO POLYMERS LIMITED IPO is open from 11 Sep 2026 to 16 Sep 2026.

What is the INJECTO POLYMERS LIMITED IPO price band?

The price band is ₹98–₹100 per share.

What is the lot size and minimum investment for the INJECTO POLYMERS LIMITED IPO?

One lot is 1200 shares, and a retail application must be at least one lot. That is about ₹2,40,000 at the upper end of the band. An HNI application starts above Rs 2 lakh, so the minimum is higher for that category.

How much is the INJECTO POLYMERS LIMITED IPO subscribed?

As of 17 Sep 2026 the total subscription is 1.29×.

When are the INJECTO POLYMERS LIMITED IPO allotment and listing dates?

Allotment is on 17 Sep 2026, as published. The listing date follows once the exchange confirms it.

How do I check the INJECTO POLYMERS LIMITED IPO allotment status?

On the allotment status page published by Integrated Registry Management, this issue's registrar, and on the exchange's basis of allotment. Those are the primary sources. If the issue was oversubscribed, retail allotment was decided by lottery, so a valid application does not mean shares. We do not hold allotment data and cannot look yours up. How allotment is actually decided →

Sources & method

Subscription and issue data come from the NSE and BSE exchange feeds, with the third-party aggregator, clearly labelled, where an exchange feed is unreachable. DRHP analysis is extracted from the offer document itself, every figure cited to its page. Each figure on the page carries its source and its timestamp.

Grey-market premium (GMP) is unregulated.

Every GMP figure is a self-reported grey-market estimate. No exchange, regulator or clearing body records or audits it, and there is no settlement guarantee or recourse. Shown for context only; never decide on GMP alone. New to GMP? The 30-second explainer → Has GMP actually been right? →

How often do these actually open above the issue price?

Of the 704 SME IPOs that have listed on the NSE since 2016, 558 (79%) opened above their issue price, at a median of +11%. That is the segment's own record, not a forecast for this issue.

See whether GMP has actually been right, issue by issue →

INJECTO POLYMERS LIMITED IPO allotment status

Allotment is on 17 Sep 2026, as published. Allotment is decided and published by the registrar, not by us. This issue's registrar is Integrated Registry Management.

Check your allotment on the registrar's own page ↗

We do not hold allotment data and cannot look yours up. If the issue was oversubscribed, retail allotment was decided by lottery, so a valid application does not mean shares. How allotment is actually decided →